Biotech (new drugs) stocks
바이오 신약
What are Biotech (new drugs) stocks in Korea?
The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩213T in total. On Oct 28, 2026 the group moved up 0.68% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 204
- Total market value
- ₩213T
- Day's move
- +0.68%
- As of
- Oct 28, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 1Q 2026
Past quarter
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Samsung Biologics | May 15 | ₩1.3T | −3.2% | ₩581B | +19.3% | +53.6% | 46.2%37.5% |
| Celltrion | May 15 | ₩1.1T | +36.0% | ₩322B | +115.4% | −32.3% | 28.1%17.7% |
| Alteogen | May 15 | ₩72B | −14.5% | ₩39B | −35.6% | +100.1% | 54.9%72.9% |
| SK biopharmaceuticals | May 15 | ₩228B | +57.8% | ₩90B | +249.7% | +94.0% | 39.4%17.8% |
| Yuhan | May 15 | ₩527B | +7.2% | ₩8.8B | +37.3% | −66.2% | 1.7%1.3% |
| HLB | May 15 | ₩19B | +5.8% | −₩23B | Smaller loss | Smaller loss | −124.1%−162.8% |
| Hanmi Pharm | May 15 | ₩393B | +0.5% | ₩54B | −9.1% | −35.6% | 13.7%15.1% |
| SK Bioscience | May 13 | ₩169B | +9.1% | −₩45B | Bigger loss | Smaller loss | −26.4%−9.8% |
| LigaChem Biosciences | May 15 | ₩36B | −30.4% | −₩37B | Turned to loss | Smaller loss | −104.3%22.1% |
| PharmaResearch | May 15 | ₩146B | +25.0% | ₩57B | +28.1% | +10.4% | 39.2%38.3% |
| ABL Bio | May 8 | ₩13B | +506.8% | −₩17B | Smaller loss | Smaller loss | −131.1%−1,341.2% |
| Hugel | May 15 | ₩117B | +29.9% | ₩48B | +22.3% | −17.6% | 40.8%43.4% |
| Peptron | May 15 | ₩2B | +21.4% | −₩5.8B | Bigger loss | Bigger loss | −293.8%−268.6% |
| Voronoi | May 15 | ₩0 | Flat | −₩22B | Bigger loss | Bigger loss | — |
| OliX Pharmaceuticals | May 15 | ₩3.6B | +265.8% | −₩11B | Bigger loss | Bigger loss | −301.9%−844.1% |
| Hanall Biopharma | May 15 | ₩40B | +10.7% | ₩839M | Turned to profit | Turned to profit | 2.1%−1.1% |
| D&D Pharmatech | May 15 | ₩129M | −90.9% | −₩11B | Bigger loss | Bigger loss | −8,636.7%−658.9% |
| Caregen | May 13 | ₩23B | +6.6% | ₩10B | +0.4% | Turned to profit | 45.0%47.7% |
| Mezzion Pharma | May 15 | ₩2B | +3.2% | −₩4.6B | Bigger loss | Smaller loss | −226.4%−180.1% |
| ST Pharm | May 15 | ₩67B | +27.7% | ₩12B | +1,024.6% | −56.1% | 17.2%2.0% |
| Seegene | May 15 | ₩129B | +11.3% | ₩24B | +58.6% | +238.9% | 18.2%12.8% |
| GC Biopharma | May 15 | ₩436B | +13.5% | ₩12B | +47.3% | +154.9% | 2.7%2.1% |
| Naturecell | May 15 | ₩4.1B | −0.4% | −₩1.3B | Smaller loss | Bigger loss | −32.6%−41.8% |
| OSCOTECInc | May 14 | ₩3.6B | +88.4% | −₩10B | Bigger loss | Turned to loss | −273.8%−429.8% |
| Aimed Bio | May 15 | ₩8.5B | — | −₩4B | — | Turned to loss | −46.6% |
| Kolon TissueGene | May 15 | ₩962,649 | +8.6% | −₩3.7M | Smaller loss | Smaller loss | −381.5%−420.8% |
| Daewoong Pharma | May 15 | ₩378B | +6.0% | ₩22B | −42.6% | −48.8% | 5.9%10.9% |
| Curiox Biosystems | May 15 | ₩1.3B | +43.7% | −₩3.3B | Bigger loss | Bigger loss | −245.5%−328.0% |
| Daewoong | May 15 | ₩493B | +2.3% | ₩48B | −21.8% | +37.4% | 9.7%12.7% |
| Chong Kun Dang Pharmaceutical | May 15 | ₩448B | +11.7% | ₩14B | +13.1% | −40.0% | 3.1%3.1% |
| Qurient | May 15 | ₩1.9B | +1.1% | −₩7.7B | Bigger loss | Smaller loss | −394.8%−350.1% |
| Chabiotech | May 15 | ₩330B | +8.4% | −₩31B | Bigger loss | Bigger loss | −9.3%−4.1% |
| Rznomics | May 15 | ₩366M | Turned to profit | −₩8.1B | Bigger loss | Bigger loss | −2,199.8% |
| G2GBIO | May 15 | ₩351M | +4,364.3% | −₩3.3B | Bigger loss | Bigger loss | −944.6%−36,553.2% |
| Pharmicell | May 12 | ₩37B | +35.7% | ₩13B | +56.1% | +36.0% | 35.6%31.0% |
| Onconic Therapeutics | May 11 | ₩23B | +150.6% | ₩4.6B | +190.6% | +184.6% | 20.0%17.2% |
| Dong-A Pharmaceutical | May 15 | ₩351B | +6.9% | ₩19B | −6.0% | +19.9% | 5.5%6.2% |
| Proteina | May 15 | ₩169M | — | −₩4.7B | — | Bigger loss | −2,795.5% |
| JW Pharmaceutical | May 15 | ₩200B | +7.9% | ₩34B | +52.6% | +117.2% | 16.8%11.9% |
| Hyundai Bioscience | May 15 | ₩325M | −54.2% | −₩4.7B | Bigger loss | Bigger loss | −1,436.9%−604.2% |
| HLB innoVation | May 15 | ₩9.4B | +25.1% | −₩10B | Bigger loss | Bigger loss | −109.9%−130.1% |
| Medy-Tox | May 15 | ₩61B | −5.1% | ₩7.4B | +34.6% | Turned to profit | 12.1%8.6% |
| GI Innovation | May 15 | ₩0 | −100.0% | −₩12B | Bigger loss | Bigger loss | — |
| Shinpoong Pharmaceutical | May 15 | ₩55B | −1.6% | −₩363M | Smaller loss | Turned to loss | −0.7%−3.2% |
| GC | May 15 | ₩535B | +8.1% | ₩3.1B | Turned to profit | Turned to profit | 0.6%−1.0% |
| Penetrium Bioscience | May 15 | ₩1.7B | −23.5% | −₩1.8B | Smaller loss | Bigger loss | −108.5%−122.9% |
| AbClon | May 15 | ₩434M | +5.2% | −₩3.1B | Smaller loss | Smaller loss | −704.5%−1,395.8% |
| GemVax & KAEL | May 15 | ₩18B | +47.6% | −₩765M | Smaller loss | Turned to loss | −4.2%−23.9% |
| HLB Life Science | May 15 | ₩15B | −44.7% | −₩6.5B | Bigger loss | Bigger loss | −42.5%−21.6% |
| IL Dong Pharmaceutical | May 15 | ₩142B | +4.4% | ₩9.2B | +120.0% | +16.4% | 6.5%3.1% |
| Curocell | May 14 | ₩0 | Flat | −₩7.8B | Bigger loss | Smaller loss | — |
| Bukwang Pharmaceutical IND | May 14 | ₩48B | −0.1% | ₩1.1B | −63.4% | −86.5% | 2.3%6.3% |
| Orum Therapeutics | May 15 | ₩0 | −100.0% | −₩18B | Bigger loss | Smaller loss | — |
| AprilBio | May 15 | ₩725M | −66.6% | −₩2.2B | Bigger loss | Bigger loss | −302.3%−5.1% |
| Medipostco | May 15 | ₩19B | +1.2% | −₩17B | Bigger loss | Smaller loss | −86.6%−71.1% |
| Dong-A ST | May 15 | ₩204B | +11.8% | ₩7.8B | Turned to profit | Turned to profit | 3.8%−2.6% |
| Inventage Lab | Jun 1 | ₩393M | +132.3% | −₩8.4B | Bigger loss | Bigger loss | −2,135.2%−3,178.1% |
| Samyang Biopharm | May 15 | ₩31B | — | ₩1.4B | — | — | 4.4% |
| SillaJen | May 15 | ₩2.9B | +146.4% | −₩5.6B | Bigger loss | Smaller loss | −198.1%−441.1% |
| ToolGen | May 14 | ₩391M | +202.6% | −₩4.6B | Smaller loss | Smaller loss | −1,175.6%−3,570.0% |
| EuBiologics | May 14 | ₩16B | −60.4% | ₩2.2B | −87.0% | −83.9% | 14.0%42.8% |
| NKGen Biotech Korea | May 15 | ₩1.6B | +10.6% | −₩1.2B | Bigger loss | Smaller loss | −76.6%−37.0% |
| ImmuneOncia Therapeutics | May 15 | ₩0 | — | −₩5.8B | — | Smaller loss | — |
| Genomictree | May 15 | ₩382M | +20.6% | −₩3B | Smaller loss | Bigger loss | −793.9%−1,177.9% |
| S.Biomedics | May 14 | ₩4.4B | −1.4% | −₩3B | Bigger loss | Bigger loss | −68.0%−37.9% |
| FutureChem | May 14 | ₩6.4B | +25.3% | −₩2.2B | Bigger loss | Bigger loss | −34.8%−37.4% |
| HLB Therapeutics | May 15 | ₩13B | −13.3% | −₩3.2B | Bigger loss | Turned to loss | −24.8%−10.5% |
| IntoCell | May 15 | ₩281M | +157.5% | −₩3.5B | Bigger loss | Bigger loss | −1,255.8%−3,122.8% |
| IMBiologics | May 14 | ₩7.2B | — | ₩2.7B | — | — | 37.8% |
| Huons | May 15 | ₩142B | −2.7% | −₩649M | Turned to loss | Turned to loss | −0.5%8.8% |
| BioPlus | May 14 | ₩27B | +15.4% | ₩5.7B | −20.4% | +487.4% | 21.3%30.9% |
| DuChemBio | May 14 | ₩9.7B | +14.7% | ₩1.3B | +87.5% | −57.9% | 12.9%7.9% |
| Genome&Company | May 15 | ₩5.8B | −9.0% | −₩6.1B | Smaller loss | Smaller loss | −105.4%−105.5% |
| GC Genome | May 15 | ₩7.4B | — | ₩140M | — | −30.2% | 1.9% |
| Binex | May 15 | ₩35B | −11.2% | −₩9B | Turned to loss | Bigger loss | −25.4%1.4% |
| 3billion | May 12 | ₩3.4B | +67.8% | −₩1.7B | Smaller loss | Bigger loss | −49.4%−98.1% |
| Bioneercorporation | May 15 | ₩82B | +10.7% | −₩526M | Turned to loss | Turned to loss | −0.6%5.9% |
| curacle | May 15 | ₩1B | — | −₩3B | Smaller loss | Smaller loss | −285.9% |
| Kangstem Biotech | May 14 | ₩805M | −15.6% | −₩4.6B | Smaller loss | Bigger loss | −567.6%−497.2% |
| Helixmith | May 15 | ₩555M | −40.4% | −₩2.2B | Smaller loss | Smaller loss | −395.9%−307.1% |
| Kolon Life Science | — | ₩50B | +10.8% | ₩2.9B | +3,839.0% | Turned to profit | 5.9%0.2% |
| Eone Diagnomics Genome Center | May 15 | ₩1.6B | −67.4% | −₩1.3B | Smaller loss | Bigger loss | −81.4%−31.0% |
| JW Lifescience | May 15 | ₩64B | −7.4% | ₩9.3B | +1.3% | +23.0% | 14.7%13.4% |
| GC Cell | May 15 | ₩37B | −5.5% | −₩5.1B | Smaller loss | Bigger loss | −13.7%−14.4% |
| Aptabio Therapeutics | May 15 | ₩957M | +150.2% | −₩6.1B | Bigger loss | Bigger loss | −636.6%−687.6% |
| Cellbion | May 14 | ₩613M | +27.7% | −₩2.4B | Bigger loss | Smaller loss | −399.0%−344.4% |
| ISU Abxis | May 15 | ₩9.5B | +31.6% | −₩3.4B | Bigger loss | Smaller loss | −36.4%−6.5% |
| Bio Solution | May 15 | ₩3.8B | +19.9% | −₩1.3B | Smaller loss | Bigger loss | −34.5%−43.9% |
| Y-Biologics | May 15 | ₩282M | −30.8% | −₩3.9B | Bigger loss | Bigger loss | −1,376.4%−554.6% |
| Aribio Holdings | May 15 | ₩7.4B | +43.4% | −₩3.1B | Bigger loss | Turned to loss | −41.6%−35.5% |
| Anterogen | May 15 | ₩2.1B | +32.5% | −₩1.1B | Bigger loss | Bigger loss | −51.8%−68.4% |
| Cell Biotech | May 15 | ₩15B | +30.0% | ₩3.2B | +134.0% | +4.3% | 21.8%12.1% |
| Kanaph Therapeutics | May 13 | ₩78M | — | −₩5.4B | — | — | −6,937.1% |
| JW Shinyak | May 15 | ₩21B | +8.8% | ₩2.9B | +331.7% | +102.5% | 13.5%3.4% |
| Hyundai Bioland | May 15 | ₩38B | +13.5% | ₩5.2B | +4.4% | Turned to profit | 13.6%14.8% |
| Macrogen | May 15 | ₩45B | +10.6% | −₩509M | Smaller loss | Turned to loss | −1.1%−7.4% |
| TiumBio | May 15 | ₩3B | +40.1% | −₩4.5B | Smaller loss | Bigger loss | −153.8%−253.8% |
| Kukjeon | May 15 | ₩35B | −9.4% | ₩2.7B | +2,248.9% | +1,864.1% | 7.7%0.3% |
| Keeps Biopharma | May 15 | ₩59B | +46.2% | −₩664M | Turned to loss | Turned to loss | −1.1%0.2% |
| ViGenCell | May 14 | ₩329M | Turned to profit | −₩2.8B | Bigger loss | Smaller loss | −862.5% |
| Celemics | May 15 | ₩923M | −46.4% | −₩1.4B | Bigger loss | Bigger loss | −154.4%−25.9% |
| HLB bioStep | May 15 | ₩13B | −0.7% | −₩2.6B | Bigger loss | Bigger loss | −19.4%−18.8% |
| Genexine | May 14 | ₩415M | +29.8% | −₩9B | Bigger loss | Smaller loss | −2,170.0%−2,652.9% |
| MedPacto | May 13 | ₩1.3B | +206.2% | −₩4.2B | Bigger loss | Bigger loss | −316.6%−882.7% |
| Asta | May 15 | ₩464M | +12.6% | −₩1.1B | Smaller loss | Bigger loss | −240.8%−397.2% |
| Metabiomed | May 15 | ₩24B | −11.8% | ₩4.9B | −13.6% | +65.1% | 19.9%20.3% |
| Aribiolab | May 15 | ₩173M | — | −₩1.7B | Smaller loss | Smaller loss | −985.0% |
| DreamCIS | May 14 | ₩17B | +22.9% | ₩539M | −59.4% | Turned to profit | 3.1%9.4% |
| iNtRON Biotechnology | May 14 | ₩1.9B | +58.7% | −₩2.2B | Bigger loss | Bigger loss | −115.0%−154.8% |
| Vaxcell-Bio Therapeutics | May 15 | ₩1.5B | −10.7% | −₩4.6B | Bigger loss | Bigger loss | −301.2%−250.4% |
| T&R Biofab | May 26 | ₩8.7B | +46.5% | −₩931M | Smaller loss | Smaller loss | −10.7%−60.1% |
| Corestemchemon | May 15 | ₩4.3B | −29.0% | −₩6B | Bigger loss | Bigger loss | −137.7%−63.1% |
| Aminologics | May 15 | ₩5.4B | +13.9% | ₩630M | +23.0% | −57.0% | 11.7%10.8% |
| Cellumed | May 15 | ₩23B | −40.3% | −₩1.6B | Smaller loss | Bigger loss | −6.7%−4.1% |
| Enzychem Lifesciences | May 13 | ₩15B | −28.3% | −₩3.2B | Bigger loss | Smaller loss | −21.8%−12.3% |
| Choong ANG Vaccine Laboratory | May 15 | ₩13B | −4.9% | ₩3B | +31.0% | +161.9% | 23.8%17.3% |
| Bio-Fd&C | May 13 | ₩4B | −7.5% | ₩1B | −28.8% | −19.5% | 25.7%33.3% |
| Pharos iBio | May 14 | — | — | −₩2.4B | Smaller loss | Smaller loss | — |
| HLB Genex | May 14 | ₩12B | +9.1% | ₩1B | +23.3% | Turned to profit | 8.6%7.6% |
| Polaris AI Pharma | May 15 | ₩14B | +7.3% | ₩606M | −17.6% | Turned to profit | 4.4%5.8% |
| SCL Science | May 15 | ₩7.7B | +237.9% | −₩648M | Smaller loss | Smaller loss | −8.5%−59.5% |
| Eye Gene | May 15 | ₩1.3B | +55.6% | −₩3.5B | Bigger loss | Bigger loss | −277.7%−305.4% |
| Choolip & Sciences | May 15 | ₩707M | +19.0% | −₩1.5B | Smaller loss | Smaller loss | −210.4%−375.4% |
| Inventera | May 15 | ₩0 | — | −₩1.9B | — | — | — |
| SunBio | May 14 | ₩1.3B | −57.4% | ₩458M | −61.5% | −78.3% | 35.5%39.3% |
| Sugentech | May 15 | ₩2.3B | +24.2% | −₩4.7B | Bigger loss | Smaller loss | −199.6%−210.2% |
| Naturalendo Tech | May 15 | ₩5.7B | −8.6% | −₩70M | Smaller loss | Smaller loss | −1.2%−11.6% |
| CTC Bio | May 12 | ₩34B | +1.0% | ₩4.6B | +401.7% | +205.3% | 13.4%2.7% |
| Amicogen | May 14 | ₩12B | +13.5% | −₩3.2B | Smaller loss | Smaller loss | −25.8%−40.0% |
| Optipharm | May 15 | ₩5.4B | +9.0% | −₩723M | Smaller loss | Bigger loss | −13.5%−23.1% |
| Pangen Biotech | May 14 | ₩3.7B | +8.4% | ₩482M | −31.2% | Turned to profit | 12.9%20.4% |
| PharmGen Science | May 15 | ₩43B | +1.0% | ₩1.8B | −13.6% | Turned to profit | 4.1%4.8% |
| Abion | May 15 | ₩574M | +30.7% | −₩6.5B | Bigger loss | Bigger loss | −1,139.7%−1,135.0% |
| Cellid | May 15 | ₩3.2B | +104.4% | −₩1.6B | Smaller loss | Smaller loss | −50.3%−172.0% |
| Tego Science | May 14 | ₩1.2B | −8.7% | −₩1.9B | Bigger loss | Smaller loss | −155.8%−67.6% |
| Adbiotech | May 15 | ₩3.1B | −11.1% | −₩1.1B | Bigger loss | Turned to loss | −34.6%−5.8% |
| HLB Panagene | May 15 | ₩3.1B | −11.6% | −₩749M | Bigger loss | Smaller loss | −23.9%−20.7% |
| NeoImmuneTech | May 15 | ₩359,672 | +3,847.7% | −₩4.2M | Smaller loss | Bigger loss | −1,180.5%−61,073.5% |
| Cytogen | May 14 | ₩6.4B | +14.0% | −₩1.5B | Smaller loss | Smaller loss | −23.1%−42.3% |
| Psomagen | May 15 | ₩8.1M | +12.2% | −₩28,419 | Smaller loss | Turned to loss | −0.4%−13.0% |
| ENCell | May 15 | ₩309M | −71.8% | −₩4.9B | Bigger loss | Smaller loss | −1,576.4%−435.8% |
| KoBioLabs | May 14 | ₩19B | +11.1% | −₩2.7B | Smaller loss | Smaller loss | −13.9%−20.0% |
| Geninus | May 15 | ₩2.4B | −9.2% | −₩2B | Smaller loss | Smaller loss | −85.8%−90.6% |
| QuadMedicine | May 15 | ₩274M | −77.0% | −₩4.4B | Bigger loss | — | −1,612.5%−281.7% |
| Aprogen | May 15 | ₩36B | +35.8% | −₩21B | Smaller loss | Smaller loss | −56.8%−84.1% |
| BL Pharmtech | May 15 | ₩1.5B | −49.2% | ₩49M | Turned to profit | Turned to profit | 3.2%−20.3% |
| GeneOne Life Science | May 15 | ₩2.6B | −69.6% | −₩2.3B | Smaller loss | Smaller loss | −90.8%−106.6% |
| CJ Bioscience | May 15 | ₩783M | −14.2% | −₩5.3B | Smaller loss | Bigger loss | −682.2%−722.7% |
| Protia | May 14 | ₩3.8B | +41.8% | ₩760M | +84.4% | −30.3% | 19.9%15.3% |
| RPbio | May 15 | ₩35B | +3.3% | ₩2.4B | +34.3% | +254.2% | 6.9%5.3% |
| Gencurix | May 8 | ₩2.1B | +23.1% | −₩1B | Smaller loss | Smaller loss | −48.0%−92.1% |
| Quratis | May 14 | ₩9.5M | −99.2% | −₩2.5B | Smaller loss | Bigger loss | −25,919.9%−223.4% |
| Gene Bio Tech | May 14 | ₩21B | −5.9% | ₩763M | +2.0% | −16.7% | 3.6%3.3% |
| Aprogen Biologics | May 14 | ₩22B | +28.3% | −₩14B | Smaller loss | Smaller loss | −63.0%−93.4% |
| Oncocross | May 14 | ₩167M | +167.3% | −₩2.5B | Bigger loss | Bigger loss | −1,503.2%−3,813.1% |
| Wonbiogen | May 12 | ₩9.3B | +12.4% | ₩2.1B | +38.1% | +0.7% | 22.8%18.6% |
| HLB Pep | May 15 | ₩1.6B | +50.9% | −₩1.8B | Bigger loss | Smaller loss | −111.5%−136.6% |
| Organoidsciences | May 15 | ₩144M | — | −₩4.2B | — | Bigger loss | −2,955.2% |
| Orientbio | Jun 19 | ₩6.6B | −14.2% | ₩50M | Turned to profit | −93.7% | 0.8%−21.1% |
| Kolmar BioTech | May 15 | ₩11B | +32.7% | ₩429M | Turned to profit | Turned to profit | 3.9%−16.9% |
| Kainos Medicine | May 15 | ₩370M | +0.4% | −₩1B | Smaller loss | Smaller loss | −273.2%−458.1% |
| IMBdx | May 15 | ₩1.3B | +27.1% | −₩2.5B | Bigger loss | Bigger loss | −192.9%−200.2% |
| Eutilex | May 14 | ₩1.3B | −38.6% | −₩2.6B | Smaller loss | Smaller loss | −206.7%−236.3% |
| Biotoxtech | May 15 | ₩12B | +5.5% | −₩1.8B | Bigger loss | Bigger loss | −15.4%−12.6% |
| Genolution | May 15 | ₩2.5B | +20.2% | −₩1.4B | Smaller loss | Smaller loss | −55.6%−120.1% |
| SLSBio(Specialty Lab Solution Bio) | May 15 | ₩958M | −45.4% | −₩950M | Bigger loss | Smaller loss | −99.2%−12.5% |
| Genematrix | May 15 | ₩2.5B | +0.9% | −₩327M | Bigger loss | Bigger loss | −13.0%−11.5% |
| Synteka Bio | May 15 | ₩422M | −51.4% | −₩3.5B | Bigger loss | Bigger loss | −830.1%−340.4% |
| C&R Research | May 14 | ₩15B | −13.4% | −₩974M | Bigger loss | Turned to loss | −6.6%−1.3% |
| GFC Life Science | May 13 | ₩5B | — | ₩464M | — | +482.3% | 9.2% |
| Shaperon | May 15 | ₩65M | +454.1% | −₩3.7B | Bigger loss | Smaller loss | −5,607.8%−30,783.7% |
| Enbioco | May 14 | ₩14B | +2.2% | ₩3.1B | −0.8% | Turned to profit | 22.1%22.8% |
| WooGene B&Gco | May 14 | ₩14B | −0.1% | ₩705M | +66.5% | +53.6% | 4.9%3.0% |
| Xcell Therapeutics | May 15 | ₩1B | +209.8% | −₩2.9B | Bigger loss | Smaller loss | −285.2%−775.8% |
| PeopleBio | May 15 | ₩643M | −17.5% | −₩1.5B | Smaller loss | Smaller loss | −230.5%−332.6% |
| Celestra | May 15 | ₩24M | −95.7% | −₩254M | Smaller loss | Bigger loss | −1,052.6%−509.7% |
| Olipass | May 15 | ₩91M | −77.4% | −₩1.8B | Smaller loss | Bigger loss | −1,958.0%−464.1% |
| From Bio | May 15 | ₩19B | +3.6% | −₩3.3B | Bigger loss | Smaller loss | −17.1%−12.5% |
| NGeneBio | May 15 | ₩12B | +487.1% | −₩1.6B | Smaller loss | Smaller loss | −13.1%−140.4% |
| BioInfra | May 15 | ₩5.5B | +1.1% | −₩2.4B | Bigger loss | — | −43.8%−40.6% |
| Phionx | May 29 | ₩915,925 | −45.4% | −₩816,373 | Smaller loss | Bigger loss | −89.1%−142.3% |
| Imgt | Not yet | ||||||
| 283100 | Not yet | ||||||
| Hans Biomed | Not yet | ||||||
| 208340 | Not yet | ||||||
| 072520 | Not yet | ||||||
| Prestige BioPharma | Not yet | ||||||
| Ingenia Therapeutics | Not yet | ||||||
| Ensol Biosciences | Not yet | ||||||
| HL Genomics | Not yet | ||||||
| Epi Biotech | Not yet | ||||||
| NovMetaPharma | Not yet | ||||||
| ProGen | Not yet | ||||||
| Plumbline Life Sciences | Not yet | ||||||
| Moogene Medi | Not yet | ||||||
| Curachem | Not yet | ||||||
| Invites Biocore | Not yet | ||||||
| Median Diagnostics | Not yet | ||||||
| AngioLab | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| Cronex | Not yet | ||||||
| OceansBio | Not yet | ||||||
| BioInfra Life Science | Not yet | ||||||
| 258540 | Not yet | ||||||
| 341170 | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 28, 2026- Above 20-day average
- 13.9%
- Above 60-day average
- 23.1%
- RSI above 70
- 0.6%
- RSI below 30
- 5.2%
- 52-week highs
- 0
- 52-week lows
- 8
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
Technical read
The Biotech (new drugs) theme covers 173 members, and only 13.9% of them trade above their 20-day averages while 23.1% sit above their 60-day averages. Eight members hit 52-week lows and none reached 52-week highs, with 5.2% of members showing RSI readings at the low extreme and 0.6% at the high extreme. The equal-weighted index gauge reads bearish on both short-term (7 bearish signals against 0 bullish) and medium-term (7 bearish, 0 bullish) measures, with RSI at 39.4 and the index positioned below its cloud.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 29, 202675Hyundai Department Store: ₩200bn of bonds due in the next 6 months vs ₩158bn cash₩200bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Hyundai Department StoreDaewonkangupHyundai G.F. HoldingsZinusHandsomeSamwonsteel
- MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
- MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
- MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom
ETFs for this theme
All ETFs →- KoAct Bio Healthcare Active₩298B+₩2.8B
- TIGER Bio TOP 10₩247B−₩2B
- TIME K Bio Active₩207B+₩6.2B
- KODEX Bio₩198B0
- TIGER Healthcare₩132B0
- TIGER Technology Transfer Bio Active₩104B−₩50M
- KODEX Healthcare₩64B−₩1.5B
- TIGER KOSDAQ 150 Biotech₩48B+₩203M
AUM · Flow 1w
Creators talking about this
Biotech (new drugs)
+0.15%바이오 신약
The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.
204 companies · 112 up · 22 flat · 70 down
- Traded value
- ₩698B
- Value vs 20-day average
- 0.77×
- Top gainer
- 3billion +11.11%
- Largest company
- Samsung Biologics ₩64T
Companies in this theme
| Company | Price | Daily | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,372,000 | −0.15% | ₩69B | ₩64T | 6.88% |
Celltrion068270 · KOSPI | ₩189,800 | +0.64% | ₩80B | ₩44T | 7.28% |
Alteogen196170 · KOSDAQ | ₩223,000 | +2.06% | ₩53B | ₩16T | 2.68% |
SK biopharmaceuticals326030 · KOSPI | ₩75,200 | +0.40% | ₩8.9B | ₩5.9T | 6.00% |
Yuhan000100 · KOSPI | ₩77,300 | −3.38% | ₩27B | ₩5.7T | 6.83% |
HLB028300 · KOSDAQ | ₩40,650 | +1.88% | ₩19B | ₩5.4T | 1.16% |
Hanmi Pharm128940 · KOSPI | ₩369,500 | +5.42% | ₩42B | ₩4.7T | 9.61% |
SK Bioscience302440 · KOSPI | ₩32,150 | +1.26% | ₩2.2B | ₩2.5T | 5.50% |
LigaChem Biosciences141080 · KOSDAQ | ₩66,200 | +3.60% | ₩13B | ₩2.5T | 4.99% |
PharmaResearch214450 · KOSDAQ | ₩228,500 | −1.30% | ₩44B | ₩2.4T | 7.14% |
ABL Bio298380 · KOSDAQ | ₩41,800 | +2.33% | ₩13B | ₩2.3T | 4.02% |
Hugel145020 · KOSDAQ | ₩181,500 | +1.17% | ₩4.8B | ₩2.3T | 2.29% |
Peptron087010 · KOSDAQ | ₩97,200 | +1.67% | ₩16B | ₩2.3T | 1.63% |
Voronoi310210 · KOSDAQ | ₩121,100 | +1.94% | ₩7.9B | ₩2.3T | 2.78% |
OliX Pharmaceuticals226950 · KOSDAQ | ₩97,300 | +7.40% | ₩22B | ₩2.2T | 5.04% |
Hanall Biopharma009420 · KOSPI | ₩38,500 | +0.65% | ₩7.1B | ₩2T | 10.56% |
D&D Pharmatech347850 · KOSDAQ | ₩42,900 | +5.15% | ₩28B | ₩2T | 1.75% |
Caregen214370 · KOSDAQ | ₩34,350 | +3.15% | ₩1.9B | ₩1.8T | 0.65% |
Mezzion Pharma140410 · KOSDAQ | ₩52,600 | −2.41% | ₩8.6B | ₩1.6T | 0.50% |
ST Pharm237690 · KOSDAQ | ₩77,200 | −3.98% | ₩29B | ₩1.6T | 5.77% |
Seegene096530 · KOSDAQ | ₩33,500 | +2.13% | ₩8.8B | ₩1.6T | 0.64% |
GC Biopharma006280 · KOSPI | ₩130,500 | +1.08% | ₩1.7B | ₩1.5T | 6.68% |
Naturecell007390 · KOSDAQ | ₩22,150 | −0.67% | ₩3.6B | ₩1.4T | 0.44% |
OSCOTECInc039200 · KOSDAQ | ₩36,650 | +2.09% | ₩3.1B | ₩1.4T | 3.87% |
Aimed Bio0009K0 · KOSDAQ | ₩20,850 | +1.46% | ₩2.4B | ₩1.4T | 0.03% |
Kolon TissueGene950160 · KOSDAQ | ₩14,600 | −1.08% | ₩4.9B | ₩1.2T | 0.57% |
Ingenia Therapeutics950260 · KOSDAQ | ₩23,600 | +1.51% | ₩5.8B | ₩1.2T | — |
Daewoong Pharma069620 · KOSPI | ₩99,900 | +0.81% | ₩2.5B | ₩1.2T | 10.30% |
Curiox Biosystems445680 · KOSDAQ | ₩62,400 | +0.16% | ₩7.3B | ₩1.1T | 1.25% |
Daewoong003090 · KOSPI | ₩14,800 | +1.93% | ₩1.4B | ₩861B | 3.25% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩61,900 | +0.98% | ₩716M | ₩854B | 6.34% |
Qurient115180 · KOSDAQ | ₩17,970 | −2.55% | ₩2.6B | ₩674B | 3.88% |
Chabiotech085660 · KOSDAQ | ₩7,080 | +0.71% | ₩1.2B | ₩658B | 0.31% |
Rznomics476830 · KOSDAQ | ₩23,400 | +3.77% | ₩4B | ₩656B | 3.96% |
G2GBIO456160 · KOSDAQ | ₩37,900 | −3.19% | ₩26B | ₩630B | 2.41% |
Pharmicell005690 · KOSPI | ₩10,230 | +4.39% | ₩4.3B | ₩614B | 2.38% |
Onconic Therapeutics476060 · KOSDAQ | ₩13,070 | +2.35% | ₩1.2B | ₩593B | — |
Dong-A Pharmaceutical000640 · KOSPI | ₩87,600 | −1.02% | ₩825M | ₩590B | 9.45% |
Proteina468530 · KOSDAQ | ₩51,500 | +5.21% | ₩10B | ₩572B | 3.78% |
JW Pharmaceutical001060 · KOSPI | ₩23,200 | +0.22% | ₩975M | ₩570B | 2.44% |
Hyundai Bioscience048410 · KOSDAQ | ₩5,870 | +0.86% | ₩7.4B | ₩566B | 0.37% |
HLB innoVation024850 · KOSDAQ | ₩14,900 | +1.36% | ₩1.5B | ₩515B | — |
Medy-Tox086900 · KOSDAQ | ₩65,800 | −2.52% | ₩903M | ₩480B | 1.44% |
GI Innovation358570 · KOSDAQ | ₩7,140 | +1.56% | ₩1.3B | ₩461B | 4.07% |
Shinpoong Pharmaceutical019170 · KOSPI | ₩8,460 | +1.32% | ₩1.4B | ₩443B | 0.39% |
GC005250 · KOSPI | ₩9,130 | +1.11% | ₩384M | ₩429B | 5.94% |
Penetrium Bioscience187660 · KOSDAQ | ₩6,660 | +4.88% | ₩5.6B | ₩426B | — |
AbClon174900 · KOSDAQ | ₩21,100 | 0.00% | ₩5.5B | ₩421B | 3.57% |
GemVax & KAEL082270 · KOSDAQ | ₩9,040 | +0.33% | ₩1.1B | ₩411B | 2.55% |
HLB Life Science067630 · KOSDAQ | ₩3,340 | −0.45% | ₩481M | ₩407B | 0.07% |
IL Dong Pharmaceutical249420 · KOSPI | ₩12,790 | +1.11% | ₩1.2B | ₩405B | 2.30% |
Curocell372320 · KOSDAQ | ₩25,000 | +2.46% | ₩1.1B | ₩381B | 0.46% |
Bukwang Pharmaceutical IND003000 · KOSPI | ₩3,750 | −0.13% | ₩818M | ₩370B | 0.68% |
Orum Therapeutics475830 · KOSDAQ | ₩16,360 | +1.80% | ₩1.5B | ₩356B | 0.09% |
AprilBio397030 · KOSDAQ | ₩12,400 | +0.49% | ₩1.3B | ₩342B | 0.95% |
Medipostco078160 · KOSDAQ | ₩8,670 | +2.12% | ₩803M | ₩340B | 1.55% |
Dong-A ST170900 · KOSPI | ₩34,900 | 0.00% | ₩337M | ₩340B | 4.78% |
Inventage Lab389470 · KOSDAQ | ₩23,950 | +5.04% | ₩1.8B | ₩319B | 0.31% |
Samyang Biopharm0120G0 · KOSPI | ₩41,550 | −1.07% | ₩1.1B | ₩309B | 1.73% |
SillaJen215600 · KOSDAQ | ₩2,120 | −0.47% | ₩1.1B | ₩294B | 0.09% |
ToolGen199800 · KOSDAQ | ₩29,800 | +6.24% | ₩854M | ₩291B | 0.43% |
EuBiologics206650 · KOSDAQ | ₩7,620 | +1.60% | ₩551M | ₩277B | 0.17% |
NKGen Biotech Korea182400 · KOSDAQ | ₩3,670 | 0.00% | ₩0 | ₩265B | — |
ImmuneOncia Therapeutics424870 · KOSDAQ | ₩2,870 | +1.41% | ₩1.1B | ₩262B | — |
Genomictree228760 · KOSDAQ | ₩10,400 | +6.89% | ₩641M | ₩259B | 0.51% |
Hans Biomed042520 · KOSDAQ | ₩17,880 | +4.50% | ₩1.4B | ₩255B | 4.88% |
Prestige BioPharma950210 · KOSPI | ₩4,220 | −16.44% | ₩3B | ₩254B | 0.15% |
S.Biomedics304360 · KOSDAQ | ₩20,150 | −0.25% | ₩792M | ₩251B | — |
FutureChem220100 · KOSDAQ | ₩8,080 | −4.04% | ₩2.6B | ₩250B | 0.76% |
HLB Therapeutics115450 · KOSDAQ | ₩2,635 | −0.57% | ₩917M | ₩249B | 0.10% |
IntoCell287840 · KOSDAQ | ₩16,300 | +2.00% | ₩351M | ₩245B | 1.04% |
IMBiologics493280 · KOSDAQ | ₩14,230 | +1.86% | ₩927M | ₩211B | — |
Huons243070 · KOSDAQ | ₩17,330 | +0.81% | ₩286M | ₩208B | 0.71% |
BioPlus099430 · KOSDAQ | ₩3,360 | +1.20% | ₩275M | ₩207B | 0.42% |
DuChemBio176750 · KOSDAQ | ₩7,160 | +1.70% | ₩2.2B | ₩204B | 0.04% |
Genome&Company314130 · KOSDAQ | ₩3,840 | −1.54% | ₩1B | ₩201B | 0.24% |
GC Genome340450 · KOSDAQ | ₩8,440 | +1.20% | ₩6.7B | ₩200B | — |
Binex053030 · KOSDAQ | ₩6,100 | +0.49% | ₩379M | ₩199B | 2.17% |
3billion394800 · KOSDAQ | ₩6,200 | +11.11% | ₩6.7B | ₩197B | 4.02% |
Bioneercorporation064550 · KOSDAQ | ₩7,070 | 0.00% | ₩1.1B | ₩182B | 0.10% |
curacle365270 · KOSDAQ | ₩8,210 | +3.53% | ₩294M | ₩182B | 0.50% |
Kangstem Biotech217730 · KOSDAQ | ₩1,863 | −0.11% | ₩387M | ₩175B | 0.10% |
Helixmith084990 · KOSDAQ | ₩3,730 | −2.10% | ₩938M | ₩172B | 0.12% |
Kolon Life Science102940 · KOSDAQ | ₩12,940 | +1.41% | ₩608M | ₩169B | 0.50% |
Eone Diagnomics Genome Center245620 · KOSDAQ | ₩741 | 0.00% | ₩0 | ₩167B | — |
JW Lifescience234080 · KOSPI | ₩10,510 | +0.67% | ₩107M | ₩166B | 0.72% |
GC Cell144510 · KOSDAQ | ₩10,470 | −19.15% | ₩3.7B | ₩165B | 0.06% |
Aptabio Therapeutics293780 · KOSDAQ | ₩5,490 | −8.96% | ₩920M | ₩154B | 0.05% |
Cellbion308430 · KOSDAQ | ₩11,940 | +5.48% | ₩281M | ₩154B | — |
ISU Abxis086890 · KOSDAQ | ₩3,595 | +1.70% | ₩232M | ₩147B | 0.20% |
Bio Solution086820 · KOSDAQ | ₩5,590 | −1.06% | ₩322M | ₩145B | 0.15% |
Y-Biologics338840 · KOSDAQ | ₩9,390 | −7.94% | ₩890M | ₩145B | 0.17% |
Aribio Holdings290690 · KOSDAQ | ₩2,700 | −1.28% | ₩650M | ₩143B | — |
Anterogen065660 · KOSDAQ | ₩13,960 | −0.14% | ₩248M | ₩140B | 0.30% |
Cell Biotech049960 · KOSDAQ | ₩14,830 | −0.54% | ₩53M | ₩139B | 0.00% |
Kanaph Therapeutics0082N0 · KOSDAQ | ₩10,030 | +2.24% | ₩866M | ₩133B | — |
JW Shinyak067290 · KOSDAQ | ₩2,375 | +0.64% | ₩2.7B | ₩133B | — |
Ensol Biosciences140610 · KONEX | ₩8,920 | +7.21% | ₩27M | ₩128B | — |
Hyundai Bioland052260 · KOSDAQ | ₩4,260 | +0.12% | ₩526M | ₩128B | 0.00% |
Macrogen038290 · KOSDAQ | ₩11,240 | +1.72% | ₩103M | ₩122B | 4.56% |
TiumBio321550 · KOSDAQ | ₩3,835 | −1.79% | ₩729M | ₩115B | 0.31% |
Kukjeon307750 · KOSDAQ | ₩2,120 | −4.07% | ₩1.3B | ₩114B | — |
Keeps Biopharma256940 · KOSDAQ | ₩5,510 | +0.36% | ₩83M | ₩111B | — |
ViGenCell308080 · KOSDAQ | ₩5,040 | −0.59% | ₩512M | ₩103B | 0.59% |
Celemics331920 · KOSDAQ | ₩9,230 | +0.11% | ₩99M | ₩103B | — |
HLB bioStep278650 · KOSDAQ | ₩5,910 | −5.89% | ₩2.5B | ₩103B | — |
Genexine095700 · KOSDAQ | ₩2,250 | −3.23% | ₩437M | ₩102B | 0.15% |
MedPacto235980 · KOSDAQ | ₩2,925 | −2.99% | ₩254M | ₩100B | 2.96% |
Asta246720 · KOSDAQ | ₩6,070 | 0.00% | ₩0 | ₩99B | — |
Metabiomed059210 · KOSDAQ | ₩3,635 | −0.68% | ₩624M | ₩99B | — |
Aribiolab261780 · KOSDAQ | ₩3,405 | +0.15% | ₩629M | ₩99B | — |
DreamCIS223250 · KOSDAQ | ₩3,870 | −2.15% | ₩960M | ₩95B | — |
iNtRON Biotechnology048530 · KOSDAQ | ₩3,045 | −0.16% | ₩437M | ₩94B | 1.38% |
Vaxcell-Bio Therapeutics323990 · KOSDAQ | ₩3,955 | −0.25% | ₩495M | ₩92B | 0.07% |
T&R Biofab246710 · KOSDAQ | ₩1,906 | −1.75% | ₩189M | ₩91B | 0.95% |
Corestemchemon166480 · KOSDAQ | ₩1,705 | +2.46% | ₩236M | ₩90B | 0.02% |
Aminologics074430 · KOSDAQ | ₩1,007 | +0.70% | ₩76M | ₩90B | — |
Cellumed049180 · KOSDAQ | ₩1,009 | 0.00% | ₩0 | ₩84B | — |
Enzychem Lifesciences183490 · KOSDAQ | ₩990 | 0.00% | ₩0 | ₩84B | 0.30% |
Choong ANG Vaccine Laboratory072020 · KOSDAQ | ₩8,830 | +0.57% | ₩32M | ₩82B | — |
Bio-Fd&C251120 · KOSDAQ | ₩9,280 | +0.32% | ₩66M | ₩81B | 0.59% |
Pharos iBio388870 · KOSDAQ | ₩5,890 | +1.38% | ₩126M | ₩76B | — |
HLB Genex187420 · KOSDAQ | ₩2,300 | +3.14% | ₩260M | ₩75B | — |
Polaris AI Pharma041910 · KOSDAQ | ₩5,640 | +1.99% | ₩145M | ₩75B | — |
Yuhan Pref.000105 · KOSPI | ₩65,200 | 0.00% | ₩66M | ₩75B | — |
SCL Science246960 · KOSDAQ | ₩2,135 | −6.97% | ₩634M | ₩74B | — |
Eye Gene185490 · KOSDAQ | ₩1,717 | −1.83% | ₩339M | ₩74B | 2.40% |
Choolip & Sciences291650 · KOSDAQ | ₩2,310 | −3.14% | ₩91M | ₩71B | — |
Inventera0007J0 · KOSDAQ | ₩8,830 | +2.32% | ₩339M | ₩69B | — |
SunBio067370 · KOSDAQ | ₩5,680 | +1.07% | ₩17M | ₩69B | — |
Sugentech253840 · KOSDAQ | ₩4,105 | +0.61% | ₩150M | ₩69B | — |
Naturalendo Tech168330 · KOSDAQ | ₩2,095 | +0.24% | ₩8.7M | ₩67B | 0.10% |
CTC Bio060590 · KOSDAQ | ₩2,685 | −1.29% | ₩85M | ₩65B | — |
Amicogen092040 · KOSDAQ | ₩915 | 0.00% | ₩244M | ₩65B | 0.37% |
Optipharm153710 · KOSDAQ | ₩4,375 | +0.57% | ₩70M | ₩64B | 0.44% |
Pangen Biotech222110 · KOSDAQ | ₩4,640 | +1.31% | ₩24M | ₩63B | — |
PharmGen Science004720 · KOSPI | ₩2,740 | −0.36% | ₩91M | ₩62B | 0.08% |
Abion203400 · KOSDAQ | ₩3,380 | 0.00% | ₩0 | ₩61B | 0.98% |
Cellid299660 · KOSDAQ | ₩2,040 | −4.00% | ₩651M | ₩60B | 0.02% |
Tego Science191420 · KOSDAQ | ₩7,400 | +6.32% | ₩57M | ₩60B | — |
Adbiotech179530 · KOSDAQ | ₩1,909 | −3.73% | ₩89M | ₩59B | — |
HLB Panagene046210 · KOSDAQ | ₩1,300 | +1.09% | ₩158M | ₩59B | — |
NeoImmuneTech950220 · KOSDAQ | ₩1,677 | +0.42% | ₩209M | ₩57B | — |
Cytogen217330 · KOSDAQ | ₩2,475 | +1.02% | ₩138M | ₩57B | — |
Psomagen950200 · KOSDAQ | ₩2,965 | +4.59% | ₩1.5B | ₩57B | — |
Imgt456570 · KONEX | ₩10,630 | −1.57% | ₩16M | ₩56B | — |
HL Genomics0156T0 · KOSDAQ | ₩7,150 | +0.42% | ₩225M | ₩56B | — |
ENCell456070 · KOSDAQ | ₩5,030 | +9.59% | ₩5.2B | ₩55B | — |
KoBioLabs348150 · KOSDAQ | ₩2,720 | −1.09% | ₩31M | ₩53B | — |
Geninus389030 · KOSDAQ | ₩1,305 | −2.25% | ₩651M | ₩51B | — |
QuadMedicine464490 · KOSDAQ | ₩4,365 | +6.72% | ₩352M | ₩50B | — |
Aprogen007460 · KOSPI | ₩1,940 | +1.36% | ₩746M | ₩50B | 0.76% |
BL Pharmtech065170 · KOSDAQ | ₩1,767 | −5.51% | ₩810M | ₩49B | — |
GeneOne Life Science011000 · KOSPI | ₩2,670 | 0.00% | ₩0 | ₩49B | 0.19% |
Epi Biotech446440 · KONEX | ₩21,000 | −4.33% | ₩231,000 | ₩48B | — |
CJ Bioscience311690 · KOSDAQ | ₩3,650 | +0.27% | ₩9.2M | ₩48B | — |
Protia303360 · KOSDAQ | ₩3,640 | −0.27% | ₩22M | ₩47B | — |
RPbio314140 · KOSDAQ | ₩5,300 | +0.57% | ₩18M | ₩46B | — |
Gencurix229000 · KOSDAQ | ₩1,957 | 0.00% | ₩0 | ₩46B | 0.81% |
NovMetaPharma229500 · KONEX | ₩3,455 | +2.07% | ₩81M | ₩45B | — |
Quratis348080 · KOSDAQ | ₩3,495 | +2.79% | ₩56M | ₩45B | — |
Gene Bio Tech086060 · KOSDAQ | ₩5,140 | +1.18% | ₩78M | ₩44B | — |
Aprogen Biologics003060 · KOSPI | ₩1,394 | +0.50% | ₩114M | ₩42B | 0.08% |
Oncocross382150 · KOSDAQ | ₩3,145 | +1.13% | ₩64M | ₩41B | — |
Wonbiogen307280 · KOSDAQ | ₩5,760 | +1.05% | ₩163M | ₩41B | — |
HLB Pep196300 · KOSDAQ | ₩4,100 | −1.09% | ₩44M | ₩39B | — |
Organoidsciences476040 · KOSDAQ | ₩5,900 | +0.85% | ₩65M | ₩39B | 1.38% |
Orientbio002630 · KOSPI | ₩1,288 | −0.69% | ₩30M | ₩38B | 0.06% |
Kolmar BioTech215380 · KOSDAQ | ₩2,140 | +1.90% | ₩90M | ₩36B | — |
Kainos Medicine284620 · KOSDAQ | ₩1,087 | 0.00% | ₩0 | ₩36B | — |
IMBdx461030 · KOSDAQ | ₩2,475 | −1.39% | ₩35M | ₩35B | 0.31% |
Eutilex263050 · KOSDAQ | ₩959 | 0.00% | ₩0 | ₩35B | 0.74% |
Biotoxtech086040 · KOSDAQ | ₩2,110 | +1.44% | ₩19M | ₩34B | — |
Genolution225220 · KOSDAQ | ₩1,717 | +0.35% | ₩61M | ₩33B | — |
ProGen296160 · KONEX | ₩2,100 | +1.94% | ₩1.9M | ₩32B | — |
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ | ₩1,969 | 0.00% | ₩0 | ₩30B | — |
Genematrix109820 · KOSDAQ | ₩1,432 | −1.24% | ₩26M | ₩29B | — |
Synteka Bio226330 · KOSDAQ | ₩1,074 | −2.81% | ₩131M | ₩26B | 0.18% |
C&R Research359090 · KOSDAQ | ₩2,205 | +1.38% | ₩16M | ₩25B | — |
GFC Life Science388610 · KOSDAQ | ₩4,480 | −1.43% | ₩211M | ₩24B | — |
Shaperon378800 · KOSDAQ | ₩2,350 | +0.21% | ₩38M | ₩22B | — |
Enbioco352940 · KOSDAQ | ₩1,901 | −1.55% | ₩9.9M | ₩21B | — |
WooGene B&Gco018620 · KOSDAQ | ₩2,770 | −1.95% | ₩74M | ₩19B | — |
Plumbline Life Sciences222670 · KONEX | ₩4,635 | 0.00% | ₩0 | ₩19B | — |
Moogene Medi322970 · KONEX | ₩1,810 | −0.55% | ₩267,125 | ₩18B | — |
Xcell Therapeutics373110 · KOSDAQ | ₩1,040 | +3.07% | ₩47M | ₩18B | — |
GC 2nd Pref.005257 · KOSPI | ₩16,450 | −1.14% | ₩1.5M | ₩14B | — |
PeopleBio304840 · KOSDAQ | ₩561 | 0.00% | ₩0 | ₩14B | — |
Celestra352770 · KOSDAQ | ₩5,250 | 0.00% | ₩0 | ₩14B | — |
Olipass244460 · KOSDAQ | ₩1,651 | 0.00% | ₩0 | ₩13B | — |
Curachem456190 · KONEX | ₩7,210 | 0.00% | ₩0 | ₩13B | — |
From Bio377220 · KOSDAQ | ₩1,909 | −1.04% | ₩171M | ₩11B | — |
NGeneBio354200 · KOSDAQ | ₩665 | −2.35% | ₩278M | ₩11B | — |
Invites Biocore216400 · KONEX | ₩1,360 | −2.79% | ₩167,554 | ₩10B | — |
JW Pharmaceutical 2nd Pref.001067 · KOSPI | ₩49,600 | −0.20% | ₩347,200 | ₩10B | — |
Median Diagnostics233250 · KONEX | ₩4,800 | 0.00% | ₩0 | ₩8.4B | — |
BioInfra199730 · KOSDAQ | ₩1,640 | +2.44% | ₩166M | ₩8B | — |
AngioLab251280 · KONEX | ₩2,170 | −12.85% | ₩9.1M | ₩7.9B | — |
JW Pharmaceutical Pref.001065 · KOSPI | ₩21,200 | +0.24% | ₩233,250 | ₩7.2B | — |
Phionx900100 · KOSDAQ | ₩1,155 | −14.44% | ₩88M | ₩6.1B | — |
Medizen Humancare236340 · KONEX | ₩1,350 | +3.85% | ₩191,200 | ₩4.1B | — |
Cronex215570 · KONEX | ₩600 | −12.41% | ₩634,595 | ₩4B | — |
OceansBio332190 · KONEX | ₩2,195 | +0.23% | ₩4,700 | ₩3.2B | — |
BioInfra Life Science266470 · KONEX | ₩99 | +4.21% | ₩180,195 | ₩2.8B | — |
Source: KRX statistical information
